The US Food and Drug Administration has requested that a court halt the unauthorized sale of e-cigarettes. Earlier, the FDA issued a marketing denial order to JUUL, instructing the company to cease sales of all their products in the United States.
In addition, electronic cigarette products currently being sold in the US market must be removed or risk facing enforcement action. These products include JUUL devices and four types of JUULpods: Virginia Tobacco flavor pods with nicotine concentrations of 5.0% and 3.0%, and Mint flavor pods with nicotine concentrations of 5.0% and 3.0%. Retailers should contact JUUL regarding any issues with their inventory.
Today's action is a commitment by the FDA to ensure that all electronic cigarettes and vaping devices currently being sold to consumers meet our public health standards," stated Dr. Robert M. Califf, FDA Commissioner. "Through the examination of electronic cigarette products that dominate the American market, we recognize the importance of these components to the availability of the products, many of which have played a disproportionate role in the rise of young people using electronic cigarettes.
2FIRSTS will continue to track this issue and update the latest developments on our “2FIRSTSAPP”. Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
